28443481|t|Impact of Abnormal DNA Methylation of Imprinted Loci on Human Spontaneous Abortion
28443481|a|Currently, there is a growing concern regarding the safety of assisted reproductive technology (ART) due to increased risk of spontaneous abortion (SA) and imprinting disorders in ART - conceived offspring. Early investigations suggested that aberrant genetic imprinting may be related to pregnancy loss; however, few studies have used human tissue specimens. Here the DNA methylation patterns of 3 imprinted genes, including maternally inherited GRB10 and the paternally inherited IGF2 and PEG3 genes, were evaluated in human chorionic villus samples by pyrosequencing and bisulfite sequencing polymerase chain reaction. The samples were divided into 4 groups: (1) SA of natural conception (NC; n = 84), (2) induced abortion of NC (n = 94), (3) SA after ART (n = 73), and (4) fetal reduction after ART (n = 86). The methylation levels and the percentages of abnormal methylation of the IGF2, GRB10, and PEG3 genes between the ART group and the NC group showed no significant difference. Both IGF2 and GRB10 genes showed higher methylation levels in the SA group compared to the non-SA group. Additionally, determining the single-nucleotide polymorphisms of 4 loci, including IGF2 rs3741205, rs3741206, rs3741211, and GRB10 rs2237457, showed that the TC+CC genotype of IGF2 rs3741211 had a 1.91-fold increased risk of SA after ART. However, there was no association between the mutant genotype of IGF2 rs3741211 and the methylation levels of IGF2 and H19, and ART might not affect the distribution of the abovementioned genotypes. It provides support for the opinion that genetic imprinting defects may be associated with SA, which might not be due to ART treatments.
28443481	0	6	Impact	T080	C4049986
28443481	10	18	Abnormal	T033	C0205161
28443481	19	34	DNA Methylation	T044	C0376452
28443481	38	52	Imprinted Loci	T028	C0678933
28443481	56	61	Human	T016	C0086418
28443481	62	82	Spontaneous Abortion	T046	C0000786
28443481	135	141	safety	T068	C0036043
28443481	145	177	assisted reproductive technology	T061	C0872104
28443481	179	182	ART	T061	C0872104
28443481	191	200	increased	T081	C0205217
28443481	201	205	risk	T078	C0035647
28443481	209	229	spontaneous abortion	T046	C0000786
28443481	231	233	SA	T046	C0000786
28443481	239	259	imprinting disorders	T047	C0012634
28443481	263	266	ART	T061	C0872104
28443481	269	278	conceived	T169	C0232908
28443481	279	288	offspring	T099	C0680063
28443481	290	295	Early	T079	C1279919
28443481	296	310	investigations	T058	C0220825
28443481	326	334	aberrant	T080	C0443127
28443481	335	353	genetic imprinting	T044	C2754720
28443481	372	386	pregnancy loss	T046	C0687675
28443481	419	424	human	T016	C0086418
28443481	425	441	tissue specimens	T024	C1292533
28443481	452	467	DNA methylation	T044	C0376452
28443481	482	497	imprinted genes	T028	C0017337
28443481	509	529	maternally inherited	T045	C4277511
28443481	530	535	GRB10	T028	C1366512
28443481	544	564	paternally inherited	T045	C4277541
28443481	565	569	IGF2	T028	C1334091
28443481	574	584	PEG3 genes	T028	C1418452
28443481	604	609	human	T016	C0086418
28443481	610	626	chorionic villus	T018	C0008508
28443481	627	634	samples	T167	C0370003
28443481	638	652	pyrosequencing	T059	C2732543
28443481	657	677	bisulfite sequencing	T063	C3831347
28443481	678	703	polymerase chain reaction	T063	C0032520
28443481	709	716	samples	T167	C0370003
28443481	737	743	groups	T078	C0441833
28443481	749	751	SA	T046	C0000786
28443481	755	773	natural conception	T033	C2113898
28443481	775	777	NC	T033	C2113898
28443481	792	808	induced abortion	T061	C0392535
28443481	812	814	NC	T033	C2113898
28443481	829	831	SA	T046	C0000786
28443481	838	841	ART	T061	C0872104
28443481	860	875	fetal reduction	T061	C0242835
28443481	882	885	ART	T061	C0872104
28443481	900	911	methylation	T044	C0376452
28443481	912	918	levels	T080	C0441889
28443481	927	938	percentages	T081	C0439165
28443481	942	950	abnormal	T033	C0205161
28443481	951	962	methylation	T044	C0376452
28443481	970	974	IGF2	T028	C1334091
28443481	976	981	GRB10	T028	C1366512
28443481	987	997	PEG3 genes	T028	C1418452
28443481	1010	1013	ART	T061	C0872104
28443481	1014	1019	group	T078	C0441833
28443481	1028	1030	NC	T033	C2113898
28443481	1031	1036	group	T078	C0441833
28443481	1044	1058	no significant	T033	C3694175
28443481	1059	1069	difference	T081	C1705241
28443481	1076	1080	IGF2	T028	C1334091
28443481	1085	1096	GRB10 genes	T028	C1366512
28443481	1111	1122	methylation	T044	C0376452
28443481	1123	1129	levels	T080	C0441889
28443481	1137	1139	SA	T046	C0000786
28443481	1140	1145	group	T078	C0441833
28443481	1162	1174	non-SA group	T078	C0441833
28443481	1206	1237	single-nucleotide polymorphisms	T086	C0752046
28443481	1241	1247	4 loci	T028	C0678933
28443481	1259	1273	IGF2 rs3741205	T028	C1334091
28443481	1275	1284	rs3741206	T028	C1334091
28443481	1286	1295	rs3741211	T028	C1334091
28443481	1301	1316	GRB10 rs2237457	T028	C1366512
28443481	1334	1348	TC+CC genotype	T032	C0017431
28443481	1352	1366	IGF2 rs3741211	T028	C1334091
28443481	1383	1392	increased	T081	C0205217
28443481	1393	1397	risk	T078	C0035647
28443481	1401	1403	SA	T046	C0000786
28443481	1410	1413	ART	T061	C0872104
28443481	1434	1436	no	T033	C1513916
28443481	1437	1448	association	T080	C0439849
28443481	1461	1467	mutant	T028	C0678941
28443481	1468	1476	genotype	T032	C0017431
28443481	1480	1494	IGF2 rs3741211	T028	C1334091
28443481	1503	1514	methylation	T044	C0376452
28443481	1515	1521	levels	T080	C0441889
28443481	1525	1529	IGF2	T028	C1334091
28443481	1534	1537	H19	T028	C1333887
28443481	1543	1546	ART	T061	C0872104
28443481	1568	1580	distribution	T169	C1704711
28443481	1603	1612	genotypes	T032	C0017431
28443481	1655	1673	genetic imprinting	T044	C2754720
28443481	1674	1681	defects	T169	C0243067
28443481	1689	1704	associated with	T080	C0332281
28443481	1705	1707	SA	T046	C0000786
28443481	1735	1738	ART	T061	C0872104
28443481	1739	1749	treatments	T061	C0087111